Shire Says Patent Deals Didn't Block Generic Adderall

By Andrew Scurria (June 10, 2013, 6:46 PM EDT) -- Shire US Inc. pushed a Florida federal judge on Friday to chuck a putative class action alleging it kept unbranded versions of wildly popular attention deficit disorder drug Adderall XR off the market, arguing that its settlements of patent litigation didn't prevent generic competition....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!